Christopher Zarins"The Institute gave us an opportunity to test our methods to see if they could work in practice instead of theory."

– Christopher Zarins, MD, Co-founder of HeartFlow



Portfolio

Since beginning operations in late 2007, The Fogarty Institute for Innovation has provided support to more than 10 innovative entrepreneurs in our "Innovation: Cultivation" program. HeartFlow, Niveus and PQ Bypass have moved on to establish independent offices. Our other innovators in residence are in various stages of development, but all are moving toward independence with astounding speed and efficiency.

Below is a summary of where each of our innovators stand to date in the development process.

In Residence

Company Technology Patient Benefit
CyberHeart The CyberHeart System uses proprietary software to allow for precise external targeting of ablation energy in the heart using radiosurgery.

View company flyer
The technology developed can treat a variety of arrhythmias and cardiovascular applications, including hypertension.
EchoPixel True 3D (t3D) is a medical visualization software solution that enables physicians to uniquely visualize and interact with image data depicting tissue and organs as if they were real physical objects.

View company flyer
Building a new world of patient care by providing visualization solutions that enable doctors to work with patient specific body parts instead of images.
G-Tech Medical

New Press Release

G-Tech Medical is developing a wireless, wearable disposable electrode patch to measure the electrical activity from the stomach, small intestine and colon.

View company flyer
Once applied the technology will allow immediately the implementation of appropriate therapeutic options rather than spending months/years of additional testing trying to rule out other serious conditions.
InPress Technologies.

New Press Release

Developing a single-use medical device to treat postpartum hemorrhage (PPH) by specifically addressing uterine atony.

View company flyer
By avoiding the use of pharmaceuticals, hysterectomy, or other invasive surgical procedures, the InPress can dramatically reduce the cost of healthcare during childbirth and save women's lives.
InterVene

New Press Release
Percutaneous approach to restoring valve competency in the deep leg veins.

View company flyer
Cure for ulcers and other painful, debilitating complications in the legs due to poor vein function.
Materna Medical Materna is working to reduce the incidence of childbirth-related injuries, and the lifelong consequences most women experience as result of vaginal delivery.

View company flyer
Our device is designed to prevent vaginal tearing and pelvic floor damage that commonly occurs during childbirth.
Medical Cue The NeoCue™ System helps nurses and doctors excel in the care of newborns by delivering dynamic, real time reminders of the standard of care, while automating complex time and data logging.

View company flyer
Improving newborn care in the labor and delivery and in the NICU. MedicalCue iscommitted to improving outcomes for newborns.
nVision nVision is an early-stage, venture backed medical device company that is dedicated to building a portfolio of novel and proprietary technologies to fill the void in female health-related innovation.

View company flyer
The first is a device which will significantly advance the diagnosis of the leading cause of female infertility, fallopian tube blockage. The second device will allow gynecologists to collect cells from the fallopian tube to further explore a patient's symptoms.
Prescient Surgical Leveraging deep expertise in infection control, Prescient is working on a technology platform and a suite of products designed to reduce the incidence of surgical site infections.

View company flyer
Hospitals today are looking to reduce readmissions, improve patient satisfaction, and eliminate deadly infections. The Prescient technology initially targets a patient segment that has the highest risk of infection: patients undergoing abdominal surgery.
Vida Systems Web-based, interactive, engaging application for anatomy and physiology education.

View company flyer
Better outcomes through education; broader patient and consumer access to health and wellness information.
Zebra Medical Technologies ZMT has developed the first clinical microscope utilizing intrinsic multiphoton techniques to provide real-time images of cellular and subcellular structures in tissues such as skin, muscle, tendon, cartilage, and bone. The company aims to improve the treatment and removal of non-melanoma skin cancers by providing histology like images of tumor margins noninvasively.

View company flyer
By empowering physicians with real-time information to determine cancer margins, we can eliminate the need for costly and time intensive histology sectioning and staining during surgical tumor removal. The patient benefits from accurate, rapid removal of cancer tissue without waiting for lab results; saving significant waiting time at the physician's office and reducing cost to the patient and payers.

Alumni

Company Technology Patient Benefit
BioParadox Point-of-care biologic treatments for cardiovascular disease.

View company flyer
Outpatient treatment for non-revascularizable ischemic cardiac and vascular disease.
HeartFlow Patient-specific, non- invasive stenosis detection. Eliminates ~1M invasive diagnostic procedures, reduces patient risk, and saves $13B/yr in healthcare costs.
Medical Sewing Solutions Miniaturized sewing machine for use in laparoscopic surgery.

View company flyer
Allows surgeons the ability to place a continuous chain of stitches with a simple system.
Medical Sewing Solutions Novel treatment for mitral valve regurgitation.

View company flyer
Minimally invasive treatment for mitral valve regurgitation vs. annuloplasty
Niveus Medical Electrical muscle stimulation for critical care patients.

View company flyer
Prevents muscle deterioration in extended-duration critical care patients.
PQ Bypass, Inc. Percutaneous treatment of peripheral vascular disease.

View company flyer
Eliminates 200K highly invasive vascular bypass surgeries per year.

© Fogarty Institute 2015Policies Newsroom Contact Us